A bimodal BI-RADS-guided GoogLeNet-based CAD system for solid breast masses discrimination using transfer learning

Lesion attention guided neural network for contrast-enhanced mammography-based biomarker status prediction in breast cancer

BACKGROUND AND OBJECTIVE

Accurate identification of molecular biomarker statuses is crucial in cancer diagnosis, treatment, and prognosis. Studies have demonstrated that medical images could be utilized for non-invasive prediction of biomarker statues. The biomarker status-associated features extracted from medical images are essential in developing medical image-based non-invasive prediction models. Contrast-enhanced mammography (CEM) is a promising imaging technique for breast cancer diagnosis. This study aims to develop a neural network-based method to extract biomarker-related image features from CEM images and evaluate the potential of CEM in non-invasive biomarker status prediction.

METHODS

An end-to-end learning convolutional neural network with the whole breast images as inputs was proposed to extract CEM features for biomarker status prediction in breast cancer. The network focused on lesion regions and flexibly extracted image features from lesion and peri‑tumor regions by employing supervised learning with a smooth L1-based consistency constraint. An image-level weakly supervised segmentation network based on Vision Transformer with cross attention to contrast images of breasts with lesions against the contralateral breast images was developed for automatic lesion segmentation. Finally, prediction models were developed following further selection of significant features and the implementation of random forest-based classification. Results were reported using the area under the curve (AUC), accuracy, sensitivity, and specificity.

RESULTS

A dataset from 1203 breast cancer patients was utilized to develop and evaluate the proposed method. Compared to the method without lesion attention and with only lesion regions as inputs, the proposed method performed better at biomarker status prediction. Specifically, it achieved an AUC of 0.71 (95 % confidence interval [CI]: 0.65, 0.77) for Ki-67 and 0.73 (95 % CI: 0.65, 0.80) for human epidermal growth factor receptor 2 (HER2).

CONCLUSIONS

A lesion attention-guided neural network was proposed in this work to extract CEM image features for biomarker status prediction in breast cancer. The promising results demonstrated the potential of CEM in non-invasively predicting the biomarker statuses in breast cancer.

Survival and grade of the glioma prediction using transfer learning

Glioblastoma is a highly malignant brain tumor with a life expectancy of only 3-6 months without treatment. Detecting and predicting its survival and grade accurately are crucial. This study introduces a novel approach using transfer learning techniques. Various pre-trained networks, including EfficientNet, ResNet, VGG16, and Inception, were tested through exhaustive optimization to identify the most suitable architecture. Transfer learning was applied to fine-tune these models on a glioblastoma image dataset, aiming to achieve two objectives: survival and tumor grade prediction.The experimental results show 65% accuracy in survival prediction, classifying patients into short, medium, or long survival categories. Additionally, the prediction of tumor grade achieved an accuracy of 97%, accurately differentiating low-grade gliomas (LGG) and high-grade gliomas (HGG). The success of the approach is attributed to the effectiveness of transfer learning, surpassing the current state-of-the-art methods. In conclusion, this study presents a promising method for predicting the survival and grade of glioblastoma. Transfer learning demonstrates its potential in enhancing prediction models, particularly in scenarios with limited large datasets. These findings hold promise for improving diagnostic and treatment approaches for glioblastoma patients.

Dynamic ECG signal quality evaluation based on persistent homology and GoogLeNet method

Cardiovascular disease is a serious health problem. Continuous Electrocardiograph (ECG) monitoring plays a vital role in the early detection of cardiovascular disease. As the Internet of Things technology continues to mature, wearable ECG signal monitors have been widely used. However, dynamic ECG signals are extremely susceptible to contamination. Therefore, it is necessary to evaluate the quality of wearable dynamic ECG signals. The topological data analysis method (TDA) with persistent homology, which can effectively capture the topological information of high-dimensional data space, has been widely studied. In this study, a brand-new quality assessment method of wearable dynamic ECG signals was proposed based on the TDA with persistent homology method. The point cloud of an ECG signal was constructed, and then the complex sequence was generated and displayed as a persistent barcode. Finally, GoogLeNet based on the transfer learning model with a 10-fold cross-validation method was used to train the classification model. A total of 12-leads ECGs Dataset and single-lead ECGs Dataset, established based on the 2011 PhysioNet/CinC challenge dataset, were both used to verify the performance of this method. In the study, 773 "acceptable" and 225 "unacceptable" signals were used as 12-leads ECGs Dataset. We relabeled 12,000 ECG signals in the challenge dataset, and treated them as single-lead ECGs Dataset after empty lead detection and balance datasets. Compared with the traditional ECG signal quality assessment method mainly based on waveform characteristics and time-frequency characteristics, the performance of the quality assessment method proposed. In this study, the classification performance of the proposed method are fairly great, mAcc = 98.04%, F1 = 98.40%, Se = 97.15%, Sp = 98.93% for 12-leads ECGs Dataset and mAcc = 98.55%, F1 = 98.62%, Se = 98.37%, Sp = 98.85% for single-lead ECGs Dataset.

Construction of machine learning-based models for cancer outcomes in low and lower-middle income countries: A scoping review

Background

The impact and utility of machine learning (ML)-based prediction tools for cancer outcomes including assistive diagnosis, risk stratification, and adjunctive decision-making have been largely described and realized in the high income and upper-middle-income countries. However, statistical projections have estimated higher cancer incidence and mortality risks in low and lower-middle-income countries (LLMICs). Therefore, this review aimed to evaluate the utilization, model construction methods, and degree of implementation of ML-based models for cancer outcomes in LLMICs.

Methods

PubMed/Medline, Scopus, and Web of Science databases were searched and articles describing the use of ML-based models for cancer among local populations in LLMICs between 2002 and 2022 were included. A total of 140 articles from 22,516 citations that met the eligibility criteria were included in this study.

Results

ML-based models from LLMICs were often based on traditional ML algorithms than deep or deep hybrid learning. We found that the construction of ML-based models was skewed to particular LLMICs such as India, Iran, Pakistan, and Egypt with a paucity of applications in sub-Saharan Africa. Moreover, models for breast, head and neck, and brain cancer outcomes were frequently explored. Many models were deemed suboptimal according to the Prediction model Risk of Bias Assessment tool (PROBAST) due to sample size constraints and technical flaws in ML modeling even though their performance accuracy ranged from 0.65 to 1.00. While the development and internal validation were described for all models included (n=137), only 4.4% (6/137) have been validated in independent cohorts and 0.7% (1/137) have been assessed for clinical impact and efficacy.

Conclusion

Overall, the application of ML for modeling cancer outcomes in LLMICs is increasing. However, model development is largely unsatisfactory. We recommend model retraining using larger sample sizes, intensified external validation practices, and increased impact assessment studies using randomized controlled trial designs

Systematic review registration

https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=308345, identifier CRD42022308345.

Image Augmentation Techniques for Mammogram Analysis

Research in the medical imaging field using deep learning approaches has become progressively contingent. Scientific findings reveal that supervised deep learning methods’ performance heavily depends on training set size, which expert radiologists must manually annotate. The latter is quite a tiring and time-consuming task. Therefore, most of the freely accessible biomedical image datasets are small-sized. Furthermore, it is challenging to have big-sized medical image datasets due to privacy and legal issues. Consequently, not a small number of supervised deep learning models are prone to overfitting and cannot produce generalized output. One of the most popular methods to mitigate the issue above goes under the name of data augmentation. This technique helps increase training set size by utilizing various transformations and has been publicized to improve the model performance when tested on new data. This article surveyed different data augmentation techniques employed on mammogram images. The article aims to provide insights into basic and deep learning-based augmentation techniques.